TRIPLOIDIES IN FIRST AND SECOND TRIMESTERS OF PREGNANCIES IN TURKEY
Yilmaz Z1, Sahin FI1,*, Tarim E2, Kuscu E2
*Corresponding Author: Yilmaz Z1, Sahin FI1,*, Tarim E2, Kuscu E2*Corresponding Author: Professor Dr. Feride Iffet Sahin, Department of Medical Genetics, Faculty of Medicine, Baskent University, Kubilay Sokak No: 36 Maltepe, 06570 Ankara, Turkey; Tel.: +90-312-2324400/138; Fax: +90-312-2319134; E-mail: feridesahin@hotmail.com
page: 71

MATERIALS AND METHODS

 A total of 1,114 amniotic fluid samples and 75 abortion samples that were karyotyped between January 2002 and December 2005 were included. Amniocentesis was made between 15 and 22 weeks of gestation due to an increased risk of chromosomal abnormalities in maternal serum screening tests that were performed in the second trimester. Cytogenetic analysis was suggested whenever the combined risk was above 1/250 for Down’s syndrome and/or combined risk above 1/100 for trisomy 18 [7].

Both extra embryonic tissue and amniotic fluid tissue cultures were set up in two separate tissue culture flasks (Greiner, Frickenhausen, Germany) with Amniomed culture medium (Biochrom, Berlin, Germany). On the 7th day of culture, the medium was changed, and when an appropriate number of mitoses was observed, the cells were harvested [8]. Chromosomes were Giemsa-trypsin (GTG) banded and at least 20 metaphases were analyzed from each sample.

Genetic counseling was given in two sessions to couples. During the first session, couples were informed about the suspicious genetic abnormality and genetic diagnosis methods after pedigree analysis. When karyotype analyses were completed and triploidy was detected, the parents were informed about the triploidy and the recurrence risks for individual karyotype findings during the second genetic counseling session. Detailed USG examination was performed in every pregnancy at 18 or 19 weeks of gestation. Pathological examination was performed in all abort ed or terminated fetuses.





Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006